Premium
Bladder squamous cell carcinoma biomarkers derived from proteomics
Author(s) -
Celis Julio E.,
Wolf Hans,
Østergaard Morten
Publication year - 2000
Publication title -
electrophoresis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.666
H-Index - 158
eISSN - 1522-2683
pISSN - 0173-0835
DOI - 10.1002/1522-2683(20000601)21:11<2115::aid-elps2115>3.0.co;2-k
Subject(s) - proteomics , basal cell , cell , urine , disease , biomarker , proteome , medicine , cancer research , pathology , oncology , bioinformatics , biology , gene , biochemistry
Proteomics provide powerful technology for analyzing the expression levels of thousands of proteins simultaneously both in health and disease. Here, we review proteomic strategies that we have developed to identify metaplastic lesions in bladder squamous cell carcinomas as well as biomarkers in the urine for follow‐up studies of squamous cell carcinoma (SCC)‐bearing patients.